Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Completed 3Terminated 2Active not recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Plasma cell 1

Conditions

Sarcoma 3Carcinoma, Renal Cell 3Leiomyosarcoma 2Solid Neoplasm 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma, Alveolar Soft Part 1Refractory or Recurrent Solid Tumor 1Recurrence 1Perivascular Epithelioid Cell Neoplasms 1Neurofibrosarcoma 1Neuroendocrine Tumors 1Nerve Sheath Neoplasms 1Liposarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1Histiocytoma, Angiomatoid Fibrous 1Granuloma, Plasma Cell 1Glioblastoma 1Fibrosarcoma 1Dermatofibrosarcoma 1Chondrosarcoma, Mesenchymal 1Chondrosarcoma, Extraskeletal Myxoid 1Carcinosarcoma 1

Interventions

Radiotherapy 3Radiation 3Doxorubicin 3pazopanib 2Nivolumab 2talimogene laherparepvec 1sotigalimab 1rucaparib 1ribociclib 1olaparib 1futibatinib 1durvalumab 1cediranib 1cabozantinib 1Temozolomide 1Specimen Handling 1PM 01183 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Gemcitabine 1Everolimus 1Erlotinib Hydrochloride 1Biopsy 1BO-112 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Leiomyosarcoma × pazopanib × Clear all
NCT02180867 2026-05-04

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

National Cancer Institute (NCI)

Phase 2/3 Active not recruiting
140 enrolled 22 charts
Plasma cellSarcoma

Histiocytoma, Angiomatoid Fibrous, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Granuloma, Plasma Cell, Leiomyosarcoma, Liposarcoma, Sarcoma, Sarcoma, Synovial, Chondrosarcoma, Mesenchymal, Dermatofibrosarcoma, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part, Nerve Sheath Neoplasms, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Perivascular Epithelioid Cell Neoplasms

NCT02203760 2024-11-15

PazoDoble

North Eastern German Society of Gynaecological Oncology

Phase 2 Active not recruiting
58 enrolled
Sarcoma

Carcinosarcoma, Leiomyosarcoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡